Case Name: Ferring Pharms., Inc. v. Burwell, Case No. 15-0802 (RC), 2016 U.S. Dist. LEXIS 121826 (D.D.C. Sept. 9, 2016) -
Drug Product and Patent(s)-in-Suit: Prepopik® (sodium picosulfate, magnesium oxide, anhydrous...more
11/7/2016
/ Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent-in-Suit ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs
Case Name: Ferring B.V. v. Actavis, Inc., Civil No. 15-4222 (SRC)(CLW), 2016 U.S. Dist. LEXIS 69328 (D.N.J. May 26, 2016) (Chesler, J.) -
Drug Product and Patents-in-Suit: Lysteda® (tranexamic acid); U.S. Patent No....more
8/2/2016
/ Abbreviated New Drug Application (ANDA) ,
Actavis Inc. ,
Federal Rule 12(b)(1) ,
Federal Rule 12(b)(6) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Watson Pharmaceuticals
Capital Dynamics AG et al. v. Cambridge Associates, LLC -
Case Number: 1:13-cv-07766-KBF (Dkt. 42) Judge Forrest granted defendant Cambridge Associate’s motion to stay the case pending the outcome of a Covered...more
Case Number: 1:12-cv-09261-TPG (Dkt. 76) -
The court denied plaintiffs’ motion to bar Par’s expert Professor Midian from receiving any of their confidential information unless he agreed to a patent prosecution bar. ...more